( 0 1 0 1 O
defined 1 8 1 8 O
as 9 11 9 11 O
10 12 14 12 14 B-lower_bound
to 15 17 15 17 O
21 18 20 18 20 B-upper_bound
days 21 25 21 25 I-upper_bound
of 26 28 26 28 O
treatment 29 38 29 38 O
with 39 43 39 43 O
vancomycin 44 54 44 54 B-treatment
[ 55 56 55 56 O
125 56 59 56 59 O
mg 60 62 60 62 O
QID 63 66 63 66 O
] 66 67 66 67 O
and/or 68 74 68 74 O
fidaxomicin 75 86 75 86 B-treatment
[ 87 88 87 88 O
200 88 91 88 91 O
mg 92 94 92 94 O
BID 95 98 95 98 O
] 98 99 98 99 O
) 99 100 99 100 O

Absolute 0 8 101 109 B-clinical_variable
neutrophil 9 19 110 120 I-clinical_variable
count 20 25 121 126 I-clinical_variable
of 26 28 127 129 O
< 29 30 130 131 O
500 30 33 131 134 B-upper_bound
cells 34 39 135 140 I-upper_bound
/ 39 40 140 141 I-upper_bound
ml3 40 43 141 144 I-upper_bound

An 0 2 145 147 O
adequate 3 11 148 156 O
clinical 12 20 157 165 O
response 21 29 166 174 O
following 30 39 175 184 O
SOC 40 43 185 188 B-treatment
antibiotic 44 54 189 199 I-treatment
therapy 55 62 200 207 I-treatment
, 62 63 207 208 O
defined 64 71 209 216 O
as 72 74 217 219 O
( 75 76 220 221 O
<3 76 78 221 223 O
unformed 79 87 224 232 O
stools 88 94 233 239 O
in 95 97 240 242 O
24 98 100 243 245 O
hours 101 106 246 251 O
) 106 107 251 252 O
for 108 111 253 256 O
2 112 113 257 258 O
or 114 116 259 261 O
more 117 121 262 266 O
consecutive 122 133 267 278 O
days 134 138 279 283 O
before 139 145 284 290 O
randomization 146 159 291 304 O

Concurrent 0 10 305 315 O
intensive 11 20 316 325 O
induction 21 30 326 335 O
chemotherapy 31 43 336 348 B-treatment
, 43 44 348 349 O
radiotherapy 45 57 350 362 B-treatment
, 57 58 362 363 O
or 59 61 364 366 O
biologic 62 70 367 375 B-treatment
treatment 71 80 376 385 I-treatment
for 81 84 386 389 O
active 85 91 390 396 B-cancer
malignancy 92 102 397 407 I-cancer
( 103 104 408 409 O
subjects 104 112 409 417 O
on 113 115 418 420 O
maintenance 116 127 421 432 O
chemotherapy 128 140 433 445 O
may 141 144 446 449 O
only 145 149 450 454 O
be 150 152 455 457 O
enrolled 153 161 458 466 O
after 162 167 467 472 O
consultation 168 180 473 485 O
with 181 185 486 490 O
the 186 189 491 494 O
study 190 195 495 500 O
medical 196 203 501 508 O
monitor 204 211 509 516 O
) 211 212 516 517 O

Female 0 6 518 524 B-gender
subjects 7 15 525 533 I-gender
who 16 19 534 537 O
are 20 23 538 541 B-pregnancy
pregnant 24 32 542 550 I-pregnancy
, 32 33 550 551 O
breastfeeding 34 47 552 565 O
, 47 48 565 566 O
lactating 49 58 567 576 O
, 58 59 576 577 O
or 60 62 578 580 O
planning 63 71 581 589 B-pregnancy
to 72 74 590 592 I-pregnancy
become 75 81 593 599 I-pregnancy
pregnant 82 90 600 608 I-pregnancy
during 91 97 609 615 O
the 98 101 616 619 O
study 102 107 620 625 O

History 0 7 626 633 O
of 8 10 634 636 O
active 11 17 637 643 B-chronic_disease
inflammatory 18 30 644 656 I-chronic_disease
bowel 31 36 657 662 I-chronic_disease
disease 37 44 663 670 I-chronic_disease
( 45 46 671 672 O
ulcerative 46 56 672 682 B-chronic_disease
colitis 57 64 683 690 I-chronic_disease
, 64 65 690 691 I-chronic_disease
Crohn 66 71 692 697 B-chronic_disease
's 71 73 697 699 I-chronic_disease
disease 74 81 700 707 I-chronic_disease
, 81 82 707 708 O
microscopic 83 94 709 720 B-chronic_disease
colitis 95 102 721 728 I-chronic_disease
) 102 103 728 729 O
with 104 108 730 734 O
diarrhea 109 117 735 743 O
believed 118 126 744 752 O
to 127 129 753 755 O
be 130 132 756 758 O
caused 133 139 759 765 O
by 140 142 766 768 O
active 143 149 769 775 O
inflammatory 150 162 776 788 O
bowel 163 168 789 794 O
disease 169 176 795 802 O
in 177 179 803 805 O
the 180 183 806 809 O
past 184 188 810 814 B-upper_bound
3 189 190 815 816 I-upper_bound
months 191 197 817 823 I-upper_bound

Major 0 5 824 829 B-treatment
gastrointestinal 6 22 830 846 I-treatment
surgery 23 30 847 854 I-treatment
( 31 32 855 856 O
e.g. 32 36 856 860 O
significant 37 48 861 872 B-treatment
bowel 49 54 873 878 I-treatment
resection 55 64 879 888 I-treatment
or 65 67 889 891 I-treatment
diversion 68 77 892 901 I-treatment
) 77 78 901 902 O
within 79 85 903 909 O
3 86 87 910 911 B-upper_bound
months 88 94 912 918 I-upper_bound
before 95 101 919 925 O
enrollment 102 112 926 936 O
( 113 114 937 938 O
this 114 118 938 942 O
does 119 123 943 947 O
not 124 127 948 951 O
include 128 135 952 959 O
appendectomy 136 148 960 972 B-treatment
or 149 151 973 975 O
cholecystectomy 152 167 976 991 B-treatment
) 167 168 991 992 O
, 168 169 992 993 O
or 170 172 994 996 O
any 173 176 997 1000 O
history 177 184 1001 1008 O
of 185 187 1009 1011 O
total 188 193 1012 1017 O
colectomy 194 203 1018 1027 B-treatment
or 204 206 1028 1030 O
bariatric 207 216 1031 1040 B-treatment
surgery 217 224 1041 1048 I-treatment
( 225 226 1049 1050 O
bariatric 226 235 1050 1059 O
surgery 236 243 1060 1067 O
which 244 249 1068 1073 O
does 250 254 1074 1078 O
not 255 258 1079 1082 O
disrupt 259 266 1083 1090 O
the 267 270 1091 1094 O
gastrointestinal 271 287 1095 1111 O
lumen 288 293 1112 1117 O
, 293 294 1117 1118 O
i.e. 295 299 1119 1123 O
, 299 300 1123 1124 O
restrictive 301 312 1125 1136 O
procedures 313 323 1137 1147 O
such 324 328 1148 1152 O
as 329 331 1153 1155 O
banding 332 339 1156 1163 O
, 339 340 1163 1164 O
are 341 344 1165 1168 O
permitted 345 354 1169 1178 O
) 354 355 1178 1179 O

The 0 3 1180 1183 O
requirement 4 15 1184 1195 O
of 16 18 1196 1198 O
CDI 19 22 1199 1202 O
SOC 23 26 1203 1206 O
antibiotic 27 37 1207 1217 B-treatment
therapy 38 45 1218 1225 I-treatment

female 0 6 1226 1232 B-gender
subject 7 14 1233 1240 O

≥ 0 1 1241 1242 O
18 2 4 1243 1245 B-lower_bound
years 5 10 1246 1251 I-lower_bound
of 11 13 1252 1254 O
age 14 17 1255 1258 B-age

≥ 0 1 1259 1260 O
3 2 3 1261 1262 B-lower_bound
unformed 4 12 1263 1271 O
stools 13 19 1272 1278 O
per 20 23 1279 1282 O
day 24 27 1283 1286 O
for 28 31 1287 1290 O
2 32 33 1291 1292 O
consecutive 34 45 1293 1304 O
days 46 50 1305 1309 O

